Custom Search

Gemfibrozil News

Tests home in on new hope against bird flu

A FLOOD of alarming reports detailing the horrors the world could expect in the event of another bird flu pandemic swept the globe in 2005 and 2006.

Marion Merrell gets approval to make generic drugs

Marion Merrell Dow Inc. said yesterday that it had received regulatory clearance to manufacture generic versions of several frequently prescribed drugs.

Administration of usual therapeutic doses of gemfibrozil considerably increases the plasma concentrations of rosiglitazone 10-fold, an insulin-sensitizing drug used to treat patients with Type 2 diabetes mellitus

Gemfibrozil, a lipid-lowering agent, was recently demonstrated to dangerously increase the plasma concentrations of another antidiabetic drug, repaglinide. Because fibrates are commonly used to lower triglyceride levels in...

Peroxisome proliferator activated receptor-α variant may predict fibrate response

A variant at the peroxisome proliferator activated receptor-α (PPARA) locus modulates the risk of cardiovascular (CV) events associated with insulin resistance and diabetes mellitus in men receiving fibrate treatment,...

Long-term followup shows dyslipidemic patients benefited from early gemfibrozil treatment

Long-term follow up showed that patients with dyslipidemia benefited from beginning treatment with gemfibrozil early, especially if their dyslipidemia entailed factors related to the metabolic syndrome.

Displaying results 1 to 5 out of 8



Next >

Use of this site is subject to the following terms of use